How Long Do the Effects of Spravato Nasal Spray Treatment Last?

Get Started
How Long Do the Effects of Spravato Nasal Spray Treatment Last?

Living with treatment-resistant depression can feel isolating and exhausting. Fortunately, advancements in medicine have brought forth new options like Spravato, an FDA-approved nasal spray medication. Spravato has captured attention for its ability to rapidly alleviate symptoms of depression, particularly in cases where traditional antidepressants haven’t provided relief. This breakthrough offers a beacon of hope, but it’s natural to wonder: how long do the effects of Spravato treatment last? We’ll be helping you delve into everything you need to know about Spravato’s duration of action, exploring both the initial onset of its effects and the timeframe for impacting your mood.

Spravato Nasal Spray Treatment

Spravato is a brand name for the medication esketamine, delivered as a nasal spray. It’s a relatively new treatment option approved by the FDA for adults struggling with depression. Spravato is typically prescribed for two specific situations: treatment-resistant depression (TRD), which refers to major depressive disorder (MDD) that hasn’t improved after trying two or more different types of oral antidepressants, and MDD with suicidal thoughts or actions, where Spravato can be used alongside an oral antidepressant if you’re experiencing MDD along with suicidal ideation or attempts.

What Does Spravato Do?

Spravato is used to manage depression in adults by providing fast-acting relief. It works by targeting the N-methyl-D-aspartate (NMDA) receptors in the brain to help regulate mood. This unique mechanism of action sets Spravato apart from traditional antidepressants, as it offers an innovative approach to depression treatment.

Furthermore, Spravato has shown promising results in clinical trials for its ability to rapidly reduce symptoms of depression, including suicidal ideation. This rapid onset of action is particularly beneficial for individuals in acute distress who require immediate relief from their depressive symptoms.

What Makes Spravato Effective?

The main active ingredient in Spravato is esketamine. Esketamine is a chemical mirror image of ketamine, another medication known for its potential antidepressant properties. Spravato contains a lower dosage of esketamine compared to ketamine, allowing for safer administration and reducing potential side effects. In addition to esketamine, Spravato also contains inactive ingredients such as benzalkonium chloride, which acts as a preservative, and sodium hydroxide to adjust the pH level of the nasal spray. These inactive ingredients play a crucial role in maintaining the stability and effectiveness of the medication throughout its shelf life, ensuring consistent quality and potency for patients.

For those struggling with depression and are seeking new treatment options, understanding the science behind Spravato’s effectiveness is very important. This innovative medication offers hope for individuals with treatment-resistant depression. Its unique mechanism of action and rapid onset differentiate it from traditional antidepressants, potentially offering a faster path to relief.

  • Targeting Glutamate Activity and NMDA Receptor Modulation
    Spravato’s active ingredient, esketamine, modulates the activity of glutamate, the brain’s most abundant excitatory neurotransmitter, and acts as an NMDA receptor antagonist. This dual action influences neurotransmitter release and neural circuit function, crucial in mood disorders like depression.
  • Rapid Onset of Action and Synaptic Rewiring
    Spravato’s effects are significantly faster than traditional antidepressants, showing improvement within hours or days. This rapid onset, along with its promotion of neuroplasticity and synaptic rewiring, helps restore healthy brain function and alleviate depressive symptoms.
  • Supervised Administration for Treatment-Resistant Depression
    Administered as a nasal spray under healthcare supervision, Spravato ensures precise dosing and close monitoring, enhancing safety and efficacy. It offers a novel treatment option for those with treatment-resistant depression, providing hope and potential symptom relief.

How Long Does Spravato Last in the Body?

Spravato, delivered through a nasal spray, exhibits a relatively rapid onset, generally taking effect within 30-60 minutes post-administration. The impact of Spravato typically persists for several hours, providing a notable window of therapeutic benefit. In certain cases, individuals may even experience residual effects for up to 24 hours after the initial administration. The substance reaches its peak in 1-2 hours and lasts several hours, indicating a sustained impact on the user. Users should be aware of the gradual onset and lingering effects of the substance, which can influence their daily activities and overall experience.

The duration of Spravato’s effects is not uniform and can be influenced by various factors unique to each individual. One crucial determinant is individual metabolism, which can affect how quickly the body processes the medication. Additionally, the dosage administered plays a role in shaping the duration and intensity of Spravato’s impact. Adherence to healthcare provider instructions is paramount, as careful attention to the prescribed frequency and timing of Spravato administration ensures an optimal balance between therapeutic benefits and potential side effects. Healthcare professionals consider individual factors when providing specific guidance, emphasizing the importance of a personalized approach to treatment.

Factors Influencing the Duration of Spravato’s Effects

There are various factors that influence the duration of Spravato’s effects. By now it is common knowledge that Spravato offers rapid relief from depressive symptoms. However, the longevity and effectiveness of its therapeutic benefits can vary significantly from person to person. This variation is influenced by a complex interplay of factors, such as:

Dosage and Frequency

Spravato treatment typically involves multiple doses administered under medical supervision. The dosage and frequency prescribed can significantly affect the duration of Spravato’s effects. Higher doses may lead to longer-lasting effects, but dosage needs to be carefully tailored to avoid potential side effects. Healthcare providers must strike a delicate balance when determining the appropriate dose and frequency, considering factors such as the severity of the condition being treated and the individual’s tolerance levels. Regular use may result in a more sustained therapeutic effect, while less frequent administration may lead to shorter-term benefits.

Individual Metabolism and Body Chemistry

Each individual metabolizes medications differently, which affects the duration of Spravato’s effects. Variations in metabolism impact how quickly the drug is processed and eliminated, influencing how long its benefits last. Personal factors such as age, weight, liver function, and overall health can also play a role. Genetic variations and enzyme activity further impact how efficiently Spravato is absorbed and eliminated from the body. Understanding these metabolic differences is crucial for healthcare providers to optimize treatment plans and achieve the desired therapeutic outcomes.

Individual Response to Treatment

Each person’s response to Spravato is unique. Factors such as individual brain chemistry, sensitivity to the medication, and the severity of the condition being treated can influence how long the effects are felt. Psychological and emotional factors, such as stress levels, mood, and mental state, can also affect how individuals perceive and respond to Spravato. These factors may indirectly impact the duration of the medication’s effects, making it essential for healthcare providers to consider each patient’s unique circumstances when prescribing and monitoring treatment.

Overall Health and Medical History

General health and medical history can significantly impact how the body processes and responds to medications like Spravato. Individuals with specific health conditions or those taking other medications may experience variations in the duration of Spravato’s effects due to potential drug interactions and underlying health issues. Healthcare providers must evaluate each patient’s medical history and monitor their progress closely to ensure optimal treatment outcomes and minimize risks.

Treatment Plan Adherence

Adherence to the prescribed treatment plan, including the recommended frequency and timing of Spravato administration, is crucial. Deviating from the prescribed regimen may impact the consistency and duration of therapeutic effects. Healthcare providers emphasize the importance of following the treatment plan precisely to achieve the best results and manage potential side effects effectively.

Spravato Nasal Spray Treatment at Marpa Minds 

There are individual variations in the factors that contribute to the uniqueness of each person’s response to Spravato. At Marpa Minds, we consider these factors when prescribing and monitoring your Spravato nasal spray medication to ensure optimal results for your treatment. 

Considering Spravato nasal spray as the right treatment option for you? Get in touch with Marpa Minds, a depression clinic in White Plains, NY, dedicated to providing you with the relief you have been seeking. Call us today at 1877-88-MARPA. 

About Author

Amy Della Rocca

PMHNP – Clinical Director
Meet Amy Della Rocca, a Psychiatric Nurse Practitioner with experience in innovative mental health treatments. Amy’s credentials hail from Columbia University and her previous work experience is in Behavioral Health, Public health and Primary Care Medicine. Amy’s unwavering belief in the potential of ketamine treatment for mental well-being stems from hands-on experience with her patients. Witnessing its positive impact and lasting changes drove her to specialize in this unique field. What sets Amy apart is her holistic approach. She considers medical, emotional, and psychological aspects, earning respect for her practical solutions. Operating from Marpa, Amy evaluates patients for Spravato compatibility. She provides comprehensive on-site care during their Spravato treatment journey. Amy supports patients from evaluation to treatment completion and collaborates with their existing mental and physical health care team. Amy’s contribution goes beyond caregiving; she actively advances Ketamine Therapy. Her expertise and dedication have garnered trust among colleagues and patients alike.